U.S., March 14 -- ClinicalTrials.gov registry received information related to the study (NCT07471958) titled 'Implementation of eHealth Delivery Alternatives for Cancer Genetic Testing for Hereditary Cancer (eREACH3)' on Nov. 13, 2025.
Brief Summary: The purpose of the study is to understand patient interest in telehealth and digital tools for pre-test genetic education and/or disclosure of genetic test results. Participants will receive telehealth genetic counseling in the home and may be offered various digital tools to help with the counseling and testing process. These are optional and participants can still speak with a genetic counselor if they wish.
Study Start Date: Sept. 02, 2025
Study Type: OBSERVATIONAL
Condition:
Cancer
Re...